CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
出版年份 2018 全文链接
标题
CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
作者
关键词
-
出版物
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-17
DOI
10.1038/s41401-018-0108-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
- (2017) John K. Simmons et al. MOLECULAR CANCER THERAPEUTICS
- U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts
- (2017) Ashley T. Tsang et al. MOLECULAR CANCER THERAPEUTICS
- Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner
- (2017) Vivek Kumar Mishra et al. NUCLEIC ACIDS RESEARCH
- HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine
- (2016) Pornpun Aramsangtienchai et al. ACS Chemical Biology
- Cellular and molecular aspects of pancreatic cancer
- (2016) A. Gharibi et al. ACTA HISTOCHEMICA
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells
- (2016) Eun-Ryeong Hahm et al. CELL CYCLE
- c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors
- (2016) Hongyan Liu et al. CLINICAL CANCER RESEARCH
- c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
- (2016) Angela Nebbioso et al. CLINICAL CANCER RESEARCH
- Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
- (2016) Kaiming Sun et al. MOLECULAR CANCER THERAPEUTICS
- Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells
- (2016) Natalie Grinshtein et al. Oncotarget
- Small-molecule inhibitors of the Myc oncoprotein
- (2015) Steven Fletcher et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration
- (2015) Ana Carolina dos Santos Ferreira et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Current status and progress of pancreatic cancer in China
- (2015) Quan-Jun Lin WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Therapeutic Strategies to Inhibit MYC
- (2014) M. R. McKeown et al. Cold Spring Harbor Perspectives in Medicine
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma
- (2013) Lei Wang et al. HEPATOLOGY
- Antagonism between FOXO and MYC Regulates Cellular Powerhouse
- (2013) Barrie Peck et al. Frontiers in Oncology
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
- (2012) C. Qian et al. CLINICAL CANCER RESEARCH
- Current concepts and novel targets in advanced pancreatic cancer
- (2012) Patrick Michl et al. GUT
- Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway
- (2011) Tsung-Hua Hsieh et al. FASEB JOURNAL
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search